FZD6 and glioma: To evaluate whether miR-433-3p modulated the progression of glioma cells by targeting FZD6, U251, and A172 cells were transfected with miR-NC, miR-433-3p, miR-433-3p + pcDNA, or miR-433-3p + FZD6.